|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7076 | |
| A61P 17/06 |
| (11) | Patento numeris | 2475371 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10763456.0 |
| Europos patento paraiškos padavimo data | 2010-09-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-07-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2010/000729 |
| Data | 2010-09-06 |
| (87) | Numeris | WO 2011/027348 |
| Data | 2011-03-10 |
| (30) | Numeris | Data | Šalis |
| 20075309 | 2009-09-06 | IL |
| (72) |
FISHMAN, Pnina, IL
|
| (73) |
Can-Fite Biopharma Ltd.,
10 Bareket Street P.O. Box 7537, Petach Tikva 49170,
IL
|
| (54) | PHARMACEUTICAL COMPOSITION COMPRISING A3 ADENOSINE RECEPTOR AGONIST (IB-MECA/CF-101) FOR TREATMENT OF PSORIASIS |
| PHARMACEUTICAL COMPOSITION COMPRISING A3 ADENOSINE RECEPTOR AGONIST (IB-MECA/CF-101) FOR TREATMENT OF PSORIASIS |